1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
Biosimilars Market by Product, Manufacturing Type, Disease - Global Forecast to 2023

Biosimilars Market: Global Forecast until 2023

  • April 2018
  • 183 pages
  • ID: 4604343
In this report:
This product segment is expected to be valued at an estimated ##,##.## million in 2018 and is projected to grow at a CAGR of ##.##% from 2018 to 2023.
The recombinant non-glycosylated proteins segment accounted for the largest share of ##.##% of the biosimilars market in 2017 and is expected to grow at a CAGR of ##.##% from 2018 to 2023.

Summary

Table of Contents

Search Inside

The overall biosimilars market forecasted to grow at a compound annual growth rate (CAGR) of 31.7% during the forecast horizon.

The biosimilars market is forecasted to reach ~$23.6B by 2023 from ~$5.9B in 2018, at a compound annual growth rate (CAGR) of 31.70 percent. Factors driving the rise of this market contain growing demand for biosimilar drugs due to their cost-effectiveness, growing incidence of chronic diseases, and strategic collaborations resulting in enhanced productivity and clinical trial activities.

The recombinant glycosylated protein segment is anticipated to rise at the quickest increase rate during the estimate period.

The biosimilars market by product, is classified into recombinant non-glycosylated proteins, recombinant glycosylated proteins, and recombinant peptides.The recombinant glycosylated proteins segment is projected to register the maximal compound annual growth rate (CAGR) during the outlook period.

The factors driving the sector for glycosylated proteins are the broad therapeutic area of these proteins; presence of biosimilar versions of monoclonal antibodies at lower prices compared to reference products; numerous biologic drugs underclass monoclonal antibody, follitropin, and erythropoietin going off-patent; and numerous products in the pipeline. The glycosylated proteins are the broad therapeutic area of these proteins; presence of biosimilar versions of monoclonal antibodies at lower prices compared to reference products; numerous biologic drugs under class monoclonal antibody, follitropin, and erythropoietin going off-patent; and numerous products in pipeline are the top factors driving the increase of this market.

The contract manufacturing segment is intended to grow at a quick rate during the analysis period.

By type of manufacturing, the biosimilars market is divided into in-house manufacturing and contract manufacturing.The contract manufacturing segment is anticipated to remain growthe at the more considerable Compound annual growth rate quickest-increasing segment of the overall biosimilars market during the estimate period.

CMOs offer cost-saving benefits to firms in terms of facilities, equipment, and labor costs. Elements such as the cost-saving of facilities, equipment, and labor are driving the increase of this segment.

Asia area is forecasted to register the highest CAGR (Compound annual growth rate) during the study period.

On the basis of area, the biosimilars market is divided into north america, Europe (EU), Asia continent, and the Rest of the globe.Asia area is anticipated to grow at the highest compound annual growth rate (CAGR) during the outlook period.

Many Asian countries including India, China (CN), South Korea (KR), and Japan (JP) have emerged as potential industries for biosimilars.Many emerging economies in the territory are also establishing biosimilar pathways.

Furthermore, leading market actors are outsourcing manufacturing and R&D activities to countries in the Asia Pacific region due to the availability of highly skilled resources at lower costs.Additionally to this, the low per capita consumption, fast growth in economies, trade links, and the increase in medical tourism are accelerating the increase of the Asian market.

Geographically, the biosimilars market is leaded by, is monopolized by EU, succeeded by Asia continent in 2018. However Asia is forecasted to grow at the quickest rate due to increasing incidences of several diseases including, diabetes, cancer, and Anaemia in Asian region and rising demand of biosimilars due to cost-effectiveness as distinguished to biologics. According to GLOBOCAN, in 2015, around 7,391,815 new cancer patients are anticipated to be diagnosed in Asia area. This growth will propel the industry demand for biosimilars required for treatment.

The primary interviews conducted for this market report can be categorized as follows:

• By Company category - Tier 1 - 70.0 percent and Tier 2 - 30.0 percent

• By Description - C- level - 62.0 percent, Director- level - 21.0 percent, Others - 17.0 percent

• By Area - North America continent - 50.0 percent, Europe (EU) - 20.0 percent, Asia- 30.0 percent

The top players in the biosimilars market contain Pfizer, Sandoz, Teva Pharmaceuticals, Amgen, Biocon, Dr. Reddy's Laboratories, Celltrion, and Samsung Biologics

Segment Research

The report analyses the biosimilars market by products, type of manufacturing, disease, and area.Apart from a comprehensive geographic product review and sizing of market, the study also offers a competitive analysis that includes the increase strategies approved by sector actors over the last three years.

Moreover, the corporation reviews contain the product types, advancements, and strategies approved by prominent market actors to maintain and rise their companies in the industry. Market research data, current market size, and forecast of the future trends will facilitate top market players and new sector entrants to make the essential decisions regarding product offerings, geographic focus, change in strategic way, and levels of output to remain successful in the market.

Main highlights

This business report will allow both established firms as well as new entrants/smaller companies to measure the pulse of the sector, which in turn will facilitate these firmsfirms, collect greater segment market share. Companies obtaining the analysis can use any one or an aggregation of the below-mentioned five strategies for strengthening their market shares.

This study furnishes highlights on the following points:

• Market Uptake: Exhaustive data on the product portfolios of the top actors in the biosimilars market

• Product Development/Innovative products: In-depth understanding on theproduct approvals, Research&development activities, and launches of new product in the biosimilars market

• opposing assessment: In-depth assessment of the market strategies, geographic and industry segments, and product review of the main players in the biosimilars market

• Market Development: Highlighted information about emerging sectors. This industry report examines the sector for different biosimilars across geographies

• industry diversification: Complete information about recent products, untapped areas, recent evolutions, and market investments in the biosimilars market

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Nicolas helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Global Biosimilars Industry

Global Biosimilars Industry

  • $ 5450
  • Industry report
  • August 2018
  • by Global Industry Analysts

This report analyzes the worldwide markets for Biosimilars in US$ Million.The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World.Annual estimates and forecasts ...

Biosimilar Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023

Biosimilar Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023

  • $ 1999
  • Industry report
  • September 2018
  • by International Market Analysis Research and Consult

The biosimilar market reached a value of US$ 2.9 Billion in 2017. This market is currently being driven by a number of factors such as patent expires of blockbuster biological drugs, lower prices, rising ...

Biosimilars: Global Markets

Biosimilars: Global Markets

  • $ 3950
  • Industry report
  • March 2018
  • by BCC Research

Report Scope:Biosimilars are replicas of the innovator biopharmaceuticals.They offer the advantage of being less expensive as compared to their expensive counterparts.The structural and manufacturing complexities ...

Biosimilars: EU Payer Perspectives $ 2558 February 2018

Global Biosimilars Market $ 4250 March 2018


ref:plp2018

Reportlinker.com © Copyright 2018. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on